MANKIND PHARMA
Back to Income Statement
|
MANKIND PHARMA Last 5 Year Profit After Tax History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Profit After Tax | ₹1,310 Cr | ₹1,453 Cr | ₹129 Cr | ₹10,561 Cr | ₹610 Cr |
What is the latest Profit After Tax of MANKIND PHARMA ?
Year | Profit After Tax |
---|---|
Mar2024 | ₹1,310 Cr |
Mar2023 | ₹1,453 Cr |
Mar2022 | ₹129 Cr |
Mar2021 | ₹10,561 Cr |
Mar2020 | ₹610 Cr |
How is Profit After Tax of MANKIND PHARMA Trending?
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2024 | ₹1,310 Cr | -9.86 | |
Mar2023 | ₹1,453 Cr | 1,023.68 | |
Mar2022 | ₹129 Cr | -98.78 | |
Mar2021 | ₹10,561 Cr | 1,630.02 | |
Mar2020 | ₹610 Cr | - |
Compare Profit After Tax of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹98,894.0 Cr | -4.4% | -7.8% | 13.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹409,003.0 Cr | -1.6% | -4.6% | 14.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,939.0 Cr | -1.6% | -1.3% | 61.6% | Stock Analytics | |
CIPLA | ₹117,835.0 Cr | 0.1% | 1.2% | 3.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,787.0 Cr | -2.1% | -8.7% | -2.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹90,722.1 Cr | -6.5% | -9.3% | 8.6% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | -4.4% |
-7.8% |
13.3% |
SENSEX | -2.5% |
-1.4% |
6.1% |
You may also like the below Video Courses